Keyword: R&D

News

Bayer Details Agrochems Outlook and Plans

22.09.2017 - Bayer Crop Science has voiced its optimism that long-term trends in the agricultural sector remained positive despite the market’s recent weakness and volatility. Speaking at the...

News

Taiwan Chemical Firms to Expand at Daesan

18.09.2017 - Acting on a government request for more domestic investment and job creation, Taiwan’s chemical industry has reportedly pledged to expand large-scale domestic investment projects...

News

AstraZeneca Sells Anesthetics Rights to Aspen

15.09.2017 - AstraZeneca has agreed to sell the remaining rights to its anesthetic drugs portfolio to Aspen Global Incorporated (AGI) in a deal worth up to $766 million. The portfolio comprises...

News

US Merck to Acquire German Biotech Rigontec

14.09.2017 - US drugmaker Merck has announced plans to acquire Germany-based Rigontec, regarded as a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway as a novel and...

News

Lilly to cut 3,500 jobs by Year-end

12.09.2017 - US pharmaceutical giant Eli Lilly has announced it will slash 3,500 positions – about 8% of its global 42,000-strong workforce up to the end of 2017. The cuts, part of a scheme to...

News

AstraZeneca and Takeda in Parkinson’s Pact

01.09.2017 - AstraZeneca and Takeda have agreed to jointly develop and commercialize a potential treatment for Parkinson’s disease. The companies will collaborate to advance MEDI1341, an...

News

Aerie and DSM in Eye Diseases Pact

10.08.2017 - US clinical stage pharmaceutical company Aerie Pharmaceuticals has entered into a research, development and license agreement with Dutch life sciences group DSM. The agreement...

News

Sanofi and Ablynx Link on Nanobody Therapeutics

04.08.2017 - French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...